Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Hepatology. 2010 Oct 1;52(6):2053–2064. doi: 10.1002/hep.23931

Fig. 4.

Fig. 4

Effect of ECAD overexpression on Smad activity. (A) Immunoblots of phosphorylated Smad3 and Smad2. MEFs stably transfected with ECAD or LX-2 cells infected with ECAD were treated with TGFβ1 (5 ng/mL). (B) Smad and TGFβ1 reporter gene activities. The data are the means and standard errors of three separate experiments [significantly different in comparison with a mock transfection (left) or a Smad3 transfection (right): **P < 0.01].